Insights

Neurodegenerative Therapeutics Pharnext focuses on developing novel therapeutics for neurodegenerative diseases, presenting a sales opportunity to healthcare institutions seeking innovative treatments for conditions lacking effective therapies.

International Phase III Trials With ongoing Phase III trials and positive results, Pharnext's lead products offer a potential partnership opportunity for pharmaceutical companies looking to collaborate on cutting-edge research and development projects in the neurodegenerative disease space.

Listed on Euronext Growth Stock Exchange As a listed company, Pharnext may be of interest to investors seeking opportunities in the biotechnology sector, providing a chance for financial institutions to explore investment options in a promising clinical-stage biopharmaceutical firm.

Advanced Technology Stack Pharnext employs a sophisticated technology stack, including Google Analytics, Joomla, and jQuery, making it an attractive prospect for technology providers offering complementary services or solutions that enhance the company's operations and research capabilities.

Competitive Positioning Amidst similar companies operating in the biotechnology research space with varying revenues and employee strengths, Pharnext's focus on neurodegenerative diseases and positive clinical trial outcomes sets it apart, positioning the company as a potential partner for firms seeking to diversify product portfolios or research pipelines.

PHARNEXT Tech Stack

PHARNEXT uses 8 technology products and services including Google Analytics, Joomla, Google Font API, and more. Explore PHARNEXT's tech stack below.

  • Google Analytics
    Analytics
  • Joomla
    Content Management System
  • Google Font API
    Font Scripts
  • MooTools
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • Bootstrap
    UI Frameworks

Media & News

PHARNEXT's Email Address Formats

PHARNEXT uses at least 1 format(s):
PHARNEXT Email FormatsExamplePercentage
FLast@pharnext.comJDoe@pharnext.com
78%
First.Last@pharnext.comJohn.Doe@pharnext.com
17%
First@pharnext.comJohn@pharnext.com
3%
FirstMiddle.Last@pharnext.comJohnMichael.Doe@pharnext.com
2%

Frequently Asked Questions

Where is PHARNEXT's headquarters located?

Minus sign iconPlus sign icon
PHARNEXT's main headquarters is located at 14 rue de la République Suresnes, Île-de-France 92150 FR. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is PHARNEXT's phone number?

Minus sign iconPlus sign icon
You can contact PHARNEXT's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PHARNEXT's stock symbol?

Minus sign iconPlus sign icon
PHARNEXT is a publicly traded company; the company's stock symbol is ALPHA.PA.

What is PHARNEXT's official website and social media links?

Minus sign iconPlus sign icon
PHARNEXT's official website is pharnext.com and has social profiles on LinkedIn.

How much revenue does PHARNEXT generate?

Minus sign iconPlus sign icon
As of July 2024, PHARNEXT's annual revenue reached $3.8M.

What is PHARNEXT's SIC code NAICS code?

Minus sign iconPlus sign icon
PHARNEXT's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PHARNEXT have currently?

Minus sign iconPlus sign icon
As of July 2024, PHARNEXT has approximately 28 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Quality Officer: M. C.Chief Financial Officer And Chief Business Officer: P. C.Vice President Clinical Operations: M. I.. Explore PHARNEXT's employee directory with LeadIQ.

What industry does PHARNEXT belong to?

Minus sign iconPlus sign icon
PHARNEXT operates in the Biotechnology Research industry.

What technology does PHARNEXT use?

Minus sign iconPlus sign icon
PHARNEXT's tech stack includes Google AnalyticsJoomlaGoogle Font APIMooToolsjQuery MigratejQueryPHPBootstrap.

What is PHARNEXT's email format?

Minus sign iconPlus sign icon
PHARNEXT's email format typically follows the pattern of . Find more PHARNEXT email formats with LeadIQ.

How much funding has PHARNEXT raised to date?

Minus sign iconPlus sign icon
As of July 2024, PHARNEXT has raised $99M in funding. The last funding round occurred on Jun 07, 2021 for $99M.

When was PHARNEXT founded?

Minus sign iconPlus sign icon
PHARNEXT was founded in 2007.
PHARNEXT

PHARNEXT

Biotechnology ResearchÎle-de-France, France11-50 Employees

Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases that currently lack curative and/or disease-modifying treatments. Pharnext has two lead products in clinical development. PXT3003 completed an international Phase III trial with positive topline results for the treatment of Charcot-Marie-Tooth disease type 1A (‘CMT1A’) and benefits from orphan drug status in Europe and the United States. An international pivotal Phase III study of PXT3003 in CMT1A, the PREMIER trial, is currently ongoing. PXT864 has generated encouraging Phase II results in Alzheimer’s disease and will be advanced through partnerships. Both of Pharnext’s lead assets originated from the Pleotherapy™ R&D approach. Pharnext draws the attention of investors to the financial and other risk factors detailed in its financial reports. More information can be found at www.pharnext.com.
Pharnext is listed on the Euronext Growth Stock Exchange in Paris.

Section iconCompany Overview

Headquarters
14 rue de la République Suresnes, Île-de-France 92150 FR
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ALPHA.PA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $99M

    PHARNEXT has raised a total of $99M of funding over 8 rounds. Their latest funding round was raised on Jun 07, 2021 in the amount of $99M.

  • $10M

    PHARNEXT's revenue is in the range of $10M

Section iconFunding & Financials

  • $99M

    PHARNEXT has raised a total of $99M of funding over 8 rounds. Their latest funding round was raised on Jun 07, 2021 in the amount of $99M.

  • $10M

    PHARNEXT's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.